Position in SUPN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$653,309
-$9,241 QoQ
Shares Held
12,639
-5.2% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026COMMERCE BANK holds $13,769,238 across 9 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
54,660 | $6,461,357 | |
| 2 | VTRS |
Viatris Inc
|
153,946 | $2,079,809 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
13,292 | $1,751,087 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
37,273 | $891,942 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,274 | $755,456 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
12,639 | $653,309 | |
| 7 | HROW |
Harrow, Inc.
|
17,430 | $614,581 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
38,310 | $364,711 |
All Filings in SUPN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $653,309 | 12,639 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $662,550 | 13,331 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $676,228 | 14,150 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $476,739 | 15,125 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $492,068 | 15,025 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $481,108 | 13,305 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $421,865 | 13,530 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $370,085 | 13,835 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $471,910 | 13,835 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $415,143 | 14,345 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $400,233 | 14,517 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $442,633 | 14,725 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $539,826 | 14,900 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $551,992 | 15,475 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $667,183 | 19,710 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $570,012 | 19,710 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $637,026 | 19,710 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $598,508 | 20,525 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $466,590 | 17,495 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $579,313 | 18,815 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $494,146 | 18,875 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $336,011 | 13,355 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $282,069 | 13,535 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $225,387 | 9,490 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||